Prevention and treatment of deep vein thrombosis and pulmonary embolism in critically III patients

Critical Care Nursing Quarterly

Volumn 28, Issue 1, 2005, Pages 72-79

  Yang, Jack C ^a  

^a SCRIPPS MERCY HOSPITAL   (United States)

Author keywords

Deep vein thrombosis; Pulmonary embolism; Thromboembolic disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; BLOOD CLOT LYSIS; CASE REPORT; CLINICAL FEATURE; COMPARTMENT SYNDROME; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL ILLNESS; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; GANGRENE; HUMAN; HYPERCOAGULABILITY; INTENSIVE CARE UNIT; LEG COMPRESSION; LEG PHLEBOGRAPHY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MALE; REVIEW; TRAFFIC ACCIDENT; ULTRASOUND; VEIN INJURY; VENOUS STASIS; VENOUS THROMBOEMBOLISM;

EID: 12944289614     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200501000-00007     Document Type: Review

References (31)

1. Attia J, Ray JG, Cook DJ, et al. Deep vein thrombosis and its prevention in critically ill patients. Arch Intern Med. 2001;161:1268-1279.
2. Geerts WH, Selby R. Prevention of venous thromboembolism in the ICU. Chest. 2003;124:357S-363S.
3. Geerts WH, Cook D, Selby R, et al. Venous thromboembolism and its prevention in critical care. J Crit Care. 2002;17:95-104.
4. Cook DJ, Laporte D, Skrobik Y, et al. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study. J Crit Care. 2001;16:161-166.
5. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-1606.
6. Hobbs R, Hampton E. Heart failure and venous thromboembolism: a major hidden risk. Br J Cardiol. 2004;11:27-32.
7. Joynt GM, Kew J, Gomersall CD, et al. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest. 2000;117:178-183.
8. Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med. 2004;164:92-96.
9. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980.
10. Spain DA, Richardson D, Polk HC, et al. Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma. 1997;42:463-469.
11. Fraisse F, Holzapfel L, Coulaud J, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med. 2000;161:1109-1114.
12. Ibrahim EH, Iregui M, Prentice D, et al. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med. 2002;30:771-774.
13. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335:701-707.
14. Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma. 2004;56:727-733.
15. Sharpe RP, Gupta R, Gracias VH, et al. Incidence and natural history of below-knee deep venous thrombosis in high-risk trauma patients. J Trauma. 2002;53:1048-1052.
16. Cipolle MD, Wojcik R, Seislove E, et al. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002;52:453-462.
17. Harris LM, Curl R, Booth FV, et al. Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. J Vasc Surg. 1997;26:764-769.
18. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119(suppl):132S-175S.
19. Dalen JE. Pulmonary embolism: what have we learned since Virchow? Chest. 2002;122:1801-1817.
20. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low intensity warfarin therapy with conventional intensity warfarin therapy for long term prevention of recurrent venous thromboembolism. N Engl J Med. 2003;349:631-639.
21. Owings JT, Blaisdell W. Low-dose heparin thromboembolism prophylaxis. Arch Surg. 1996;131: 1069-1073.
22. Knudson MM, Morabito D, Paiement GD, et al. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma. 1996;41:446-459.
23. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 1999;341:793-800.
24. Offner PJ, Hawkes A, Madayag R, et al. The role of temporary inferior vena cava filters in critically ill surgical patients. Arch Surg. 2003;138:591-595.
25. Merli G, Spiro TE, Olsson CG, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med. 2001;134:191-202.
26. Buller HR, Davidson BL, Decousus H, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. Ann Intern Med. 2004;140:867-873.
27. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med. 1995;332:1661-1665.
28. Kearon C, Gent D, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340:901-907.
29. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med. 2001;345:165-169.
30. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143-1150.
31. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med. 1998;338:409-415.